UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 29, 2017

GREAT BASIN SCIENTIFIC, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-36662		83-0361454
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

420 E. South Temple, Suite 520, Salt Lake City, UT

(Address of principal executive offices)

84111

(Zip code)

(888) 333-9763

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:


☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☑

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On August 16, 2017, Great Basin Scientific, Inc. (the “Company”) disclosed in its Current Report on Form 8-K that the Company was not able to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2017 (“Form 10-Q”) which was due on August 14, 2017. On September 28, 2017, the Company disclosed in its Current Report on Form 8-K that the Company will not be able to file its Form 10-Q by the September 28, 2017 deadline to remain eligible for trading on the OTCQB market. On September 29, 2017, the Company received notice from the OTC Markets Group that due to the Company’s ongoing delinquency in the filing of its Form 10-Q, the Company will be moved from the OTCQB market to OTC Pink market before market opens on Monday, October 2, 2017.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


		GREAT BASIN SCIENTIFIC, INC.


Date: September 29, 2017	By:	/s/ Ryan Ashton
		Ryan Ashton
		President and Chief Executive Officer

Great Basin Scientific, Inc. 8-K